Skip to main content

Table 4 Response to chemotherapy (n = 402)

From: Prognostic significance of a systemic inflammatory response in patients receiving first-line palliative chemotherapy for recurred or metastatic gastric cancer

Response No of Patient %
CR 25 6.2
PR 120 29.9
SD 140 34.8
PD 103 25.6
ORR (CR + PR) 145 36.1
DCR (CR + PR + SD) 285 70.9
NE 14 3.5
Total 402 100.0
  1. CR: complete response, PR: partial response, SD: stable disease, PD: progressive disease, ORR: overall response rate, DCR: disease control rate, NE: not evaluable